Philips debuts Alice NightOne at-home sleep disorder diagnostic system

June 4, 2015

ANDOVER, MA.  – Philips Respironics, a business of Royal Philips (NYSE: PHG AEX: PHIA), today unveiled Alice NightOne, an at home sleep testing system (HST).  As the sleep lab industry adjusts to keep pace with the demands of value-based care and changing reimbursement requirements, Alice NightOne enables the efficient identification and treatment of sleep disorder patients.  Fully compatible with the Philips Somnolyzer scoring solution, sleep technicians can read the results from the Alice NightOne HST and determine a sleep study score in 50-85 percent less time and with great accuracy*.


“Conventional laboratory-based sleep testing or polysomnography can pose challenges for sleep clinicians and patients, including limited availability and cost,” said Teofilo Lee-Chiong, M.D., Chief Medical Liaison, Philips. “This latest, intuitive testing option allows reliable and accurate diagnosis of sleep disordered breathing that is more accessible and efficient. More importantly, it gives patients the option of having a sleep test in the comfort of their own home, which may improve overall patient experience and drive better outcomes.”


Speeding time to diagnosis and treatment

By eliminating the long wait times for an appointment and discomfort some patients associate with in-lab sleep studies, Alice NightOne can speed the time to diagnosis and treatment. With minimal sensors and intuitive icons, Alice NightOne is easy for patients to set up themselves and limits discomfort while they sleep*.  It includes Smart Guide technology that provides step-by-step instructions and feedback to ensure all functions are working properly, reducing the chance of patient error. The device indicates if additional testing may be required before the patient returns the equipment, further streamlining logistics. Along with enabling sleep technicians to identify an appropriate score faster*, Alice NightOne also provides the data necessary to differentiate between obstructive, central and positional sleep apnea.


Connecting care across the sleep patient’s journey

Alice NightOne is the latest in a suite of sleep disorder diagnostic and treatment products from Philips that provide support at every point along the sleep patient’s journey.  Philips entire portfolio of sleep solutions is designed to connect care across the health continuum and address the challenges patients and clinicians face in diagnosis, adherence and long-term sleep therapy compliance. 


Alice NightOne will be on display at the Philips Respironics booth (#601) at SLEEP 2015, the annual joint meeting of the American Academy of Sleep Medicine and Sleep Research Society.  For more information on Philips’ advanced solutions for sleep and respiratory care, visit and follow @PhilipsHealth.


* Data on file, Philips internal study

For further information, please contact:

Alicia Cafardi


Tel: +1 724-387-4439




About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at


You are about to visit a Philips global content page

You are about to visit the Philips USA website.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.